共 50 条
- [1] Combination checkpoint immunotherapy and cytotoxic chemotherapy: Further results from a phase Ib/II trial of pembrolizumab and docetaxel or gemcitabine in patients with advanced or metastatic urothelial cancer.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)Parikh, MamtaPan, Chong-XianBeckett, LaurelLi, YuejuRobles, DanielDeVisser, ChristinaLara, Primo
- [2] Combination checkpoint immunotherapy and cytotoxic chemotherapy: Pembrolizumab (Pembro) plus either docetaxel or gemcitabine in patients with advanced or metastatic urothelial cancer.JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)Lara, PrimoBeckett, LaurelLi, YuejuParikh, MamtaRobles, DanielAujla, Pawandeep
- [3] Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I StudyCLINICAL GENITOURINARY CANCER, 2018, 16 (06) : 421 - +Parikh, MamtaPan, Chong-XianBeckett, Laurel A.Li, YuejuRobles, Daniel A.Aujla, Pawandeep K.Lara, Primo N., Jr.
- [4] A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancerAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (02): : 109 - 113Artz, AStadler, WMVogelzang, NJZimmerman, TRyan, C
- [5] Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trialANNALS OF ONCOLOGY, 2002, 13 (02) : 243 - 250Pectasides, DGlotsos, JBountouroglou, NKouloubinis, AMitakidis, NKarvounis, NZiras, NAthanassiou, A
- [6] Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA TrialCLINICAL CANCER RESEARCH, 2024, 30 (10) : 2111 - 2120Voisin, AllisonTerret, CatherineSchiffler, CamilleBidaux, Anne-SophieVanacker, HelenePerrin-Niquet, MarleneBarbery, MaudVinceneux, ArmelleEberst, LaurianeStephan, PierreGarin, GwenaeleSpaggiari, DanyPerol, DavidGrinberg-Bleyer, YenkelCassier, Philippe A.
- [7] Salvage chemotherapy of metastatic breast cancer with docetaxel and Gemcitabine: A multicenter phase II trialANNALS OF ONCOLOGY, 1998, 9 : 19 - 19Mavroudis, DMalamos, NGiannakakis, TAlexopoulos, APotamianou, ARigatos, GKosmas, CSarra, EPapadouris, SGeorgoulias, V
- [8] A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC)ANNALS OF ONCOLOGY, 2018, 29 : 726 - 726Hoimes, C. J.Albany, C.Hoffman-Censits, J.Fleming, M. T.Trabulsi, E.Picus, J.Cary, C.Koch, M. O.Walling, R.Kelly, W.Godwin, J. L.Cooney, M.Fu, P.Nelson, A.Patel, K.Eitman, C.Breen, T.Neal, A.Kaimakliotis, H.
- [9] Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancerJOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1921 - 1927Kaufman, DRaghavan, DCarducci, MLevine, EGMurphy, BAisner, JKuzel, TNicol, SOh, WStadler, W
- [10] Gemcitabine and oxaliplatin combination:: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancerANNALS OF ONCOLOGY, 2006, 17 : 151 - 152Carles, JoanEsteban, E.Climent, M.Font, A.Gonzalez-Larriba, J. L.Berrocal, A.Fabregat, X.Albanell, J.Bellmunt, J.